Gilva Therapeutics, INC. announced that it will issue 30,000,000 shares at a price of TWD 1 per share for gross proceeds for TWD 30,000,000 on March 5, 2024. The transaction include the participation from new investor Alar Pharmaceuticals Inc. The transaction has been approved at the Board of Directors of the company.